This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Feb 28;285(8):1013.

doi: 10.1001/jama.285.8.1013.

Underuse of beta-blockers following myocardial infarction

D Budnitz, W R Neuman

PMID: 11209161
DOI: 10.1001/jama.285.8.1013

Comment

Underuse of beta-blockers following myocardial infarction

D Budnitz et al. JAMA. 2001.

. 2001 Feb 28;285(8):1013.

doi: 10.1001/jama.285.8.1013.

Authors

D Budnitz, W R Neuman

PMID: 11209161
DOI: 10.1001/jama.285.8.1013

No abstract available

PubMed Disclaimer

Comment on

Better care and better outcomes: the continuing challenge.
Naylor CD. Naylor CD. JAMA. 1998 May 6;279(17):1392-4. doi: 10.1001/jama.279.17.1392. JAMA. 1998. PMID: 9582048 No abstract available.
Health and economic benefits of increased beta-blocker use following myocardial infarction.
Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Phillips KA, et al. JAMA. 2000 Dec 6;284(21):2748-54. doi: 10.1001/jama.284.21.2748. JAMA. 2000. PMID: 11105180

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information